A Multicenter, Randomized, Double-blind, Parallel Group Trial to Demonstrate the Efficacy of Fondaparinux Sodium in Association With Intermittent Pneumatic Compression (IPC) Versus IPC Used Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdomi
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Acronyms APOLLO
- Sponsors GlaxoSmithKline; GSK
Most Recent Events
- 24 Apr 2008 Status changed from in progress to completed. reported by ClinicalTrials.gov.
- 18 Sep 2007 Results have been reported.
- 14 Sep 2006 New trial record.